Global Geographic Atrophy Market Analysis

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Global Geographic Atrophy Market Analysis

  • Pharmaceutical
  • Upcoming Report
  • Dec 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

The Global Geographic Atrophy (GA) Market is driven by the increasing prevalence of age-related macular degeneration (AMD), of which GA is an advanced form. According to the BrightFocus Foundation, approximately 196 million people worldwide are affected by AMD, with an estimated 10-15% progressing to GA. The prevalence of GA significantly increases with age, impacting nearly 5% of individuals over 75 years old in developed regions like the U.S. and Europe. Advances in diagnostic imaging, such as Optical Coherence Tomography (OCT), have improved early detection rates, allowing for timely intervention. Additionally, the market is bolstered by rising awareness of GA among aging populations and ongoing research into innovative therapies targeting the complement pathway and neuroprotection. However, the lack of curative treatments remains a critical challenge, underscoring the urgent need for novel therapeutic developments.

Filled Map Analysis

Frequently Asked Questions

The market is segmented based on Segmentation, By Drug Class (Anti-VEGF (Vascular Endothelial Growth Factor) Agents, Complement Pathway Inhibitors, Cell and Gene Therapies, Other Therapeutics), Route of Administration (Intravitreal, Oral, Others), Gender (Male, Female), End User (Hospitals, Ophthalmic Clinics, Homecare Settings), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Industry Trends and Forecast to 2032 .
The Global Geographic Atrophy Market size was valued at USD 1.78 USD Billion in 2024.
The Global Geographic Atrophy Market is projected to grow at a CAGR of 9.6% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, Rest of South America.